|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��ԭ��,ɳ�� |
|
��ֳ�� |
|
ģ��,���� |
| ��������������� | |
|
����� |
|
��ȫ�� |
| PubMed | |
|
Article by |
|
Article by |
ɳ����ԭ����ֳ����Ⱦ����ģ�͵��о���չ
�����, ��ȫ��
���ҽ�ƴ�ѧ��ҽԺƤ���Բ��� 300052
ɳ����ԭ����������Դ���������ԭ��֮һ,����������ֳϵͳ����������ٵĸ�Ⱦ�������²��в���,Ȼ�����²�����Ŀǰ��δ��ȫ���ˡ��������ʵĶ���ģ�����˽�ɳ����ԭ���Ⱦ�²����ơ����ߡ�����������չ�����Լ�����ҩ����Ч�Ͷ��Թ۲졢�������ƺ���������Ч�������ȵ�����������
[2] Ito JI Jr, Harrison HR, Alexander ER, et al. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J Infect Dis, 1984, 150:577-582.
[3] de la Maza LM, Pal S, Khamesipour A, et al. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun, 1994, 62:2094-2097.
[4] Ramsey KH, DeWolfe JL, Salyer RD. Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis. Infect Immun, 2000, 68:7186.
[5] Meijer A, Morre SA, van den Brule AJ, et al. Genomic relatedness of Chlamydia isolates determined by amplified fragment length polymorphism analysis. J Bacteriol,1999,181:4469-4475.
[6] Perry LL, Su H, Feilzer K, et al. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol, 1999, 162:3541-3548.
[7] Read TD, Brunham RC, Shen C, et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res, 2000, 28:1397-1406.
[8] Belland RJ, Scidmore MA, Crane DD, et al. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A, 2001, 98:13984-13989.
[9] Morre SA, Lyons JM, Ito JI Jr. Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains. Infect Immun, 2000, 68:7209-7211.
[10] Rank RG, Bowlin AK, Reed RL, et al. Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose. Infect Immun, 2003, 71:6148-6154.
[11] Kaushic C, Murdin AD, Underdown BJ, et al. Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response. Infect Immun, 1998, 66:893-898.
[12] Kaushic C, Zhou F, Murdin AD,et al. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect Immun, 2000, 68:4207-4216.
[13] Everett KD. Chlamydia and Chlamydiales: more than meets the eye. Vet Microbiol, 2000, 75:109-126.
[14] Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol, 1999, 49:415-440.
[15] Guseva NV, Knight ST, Whittimore JD, et al. Primary cultures of female swine genital epithelial cells in vitro: a new approach for the study of hormonal modulation of Chlamydia infection. Infect Immun, 2003, 71:4700-4710.
[16] Davis CH, Raulston JE, Wyrick PB. Protein disulfide isomerase, a component of the estrogen receptor complex, is associated with Chlamydia trachomatis serovar E attached to human endometrial epithelial cells. Infect Immun, 2002, 70:3413-3418.